KPMNG Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors II

NCT05525858 · clinicaltrials.gov ↗

RECRUITING

Status

1000

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor
Advanced Solid Tumor
Metastatic Cancer

Interventions

DRUG: Alectinib
DRUG: Atezolizumab
DRUG: Erlotinib
DRUG: Trastuzumab + Pertuzumab
DRUG: Trastuzumab emtansine
DRUG: Vemurafenib
DRUG: Bevacizumab + Erlotinib
DRUG: Entrectinib
DRUG: Pralsetinib

Sponsor

Seoul National University Bundang Hospital

Collaborators

[object Object]
[object Object]